Showing results (381-390 of 468) with videos related to

Sort By:
Pageof 47
JACC. Cardiovascular Interventions|November 24, 2018
The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION RegistryJohn A Dodson, Judith S Hochman, Matthew T Roe, et al.
Archives of Internal Medicine|October 13, 2006
Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiativeRajendra H Mehta, Matthew T Roe, Anita Y Chen, et al.
American Heart Journal|June 5, 2017
Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularizationAnthony J Dalby, Shmuel Gottlieb, Derek D Cyr, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Journal of the American College of Cardiology|December 28, 2016
Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data RegistriesFrederick A Masoudi, Angelo Ponirakis, James A de Lemos, et al.
Physiological Genomics|September 19, 2019
Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndromeLydia Coulter Kwee, Megan L Neely, Elizabeth Grass, et al.
The American Journal of Cardiology|February 8, 2006
Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)Deborah B Diercks, W Frank Peacock, Brian C Hiestand, et al.
American Heart Journal|September 26, 2006
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiativeManesh R Patel, Anita Y Chen, Eric D Peterson, et al.
Clinical Chemistry|May 19, 2017
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary SyndromeMark Y Chan, Megan L Neely, Matthew T Roe, et al.
American Heart Journal|December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trialJeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
Pageof 47